Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
11.74
-0.26 (-2.17%)
Mar 9, 2026, 2:49 PM EDT - Market open
Carlsmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Revenue | 50.51 | 27.17 | 13.78 |
| Revenue Growth (YoY) | 85.94% | 97.16% | - |
| Cost of Revenue | 12.47 | 7.12 | 3.88 |
| Gross Profit | 38.04 | 20.05 | 9.9 |
| Selling, General & Admin | 51.6 | 29.87 | 21.1 |
| Research & Development | 17.02 | 14.3 | 7.4 |
| Operating Expenses | 68.61 | 44.17 | 28.49 |
| Operating Income | -30.57 | -24.12 | -18.59 |
| Interest Expense | -1.43 | -1.32 | -0.64 |
| Interest & Investment Income | 2.7 | 1.33 | 0.33 |
| Other Non Operating Income (Expenses) | -0.33 | -0.14 | - |
| Pretax Income | -29.63 | -24.26 | -18.9 |
| Net Income | -29.63 | -24.26 | -18.9 |
| Preferred Dividends & Other Adjustments | 0.58 | 0.59 | - |
| Net Income to Common | -30.22 | -24.85 | -18.9 |
| Shares Outstanding (Basic) | 14 | 4 | 4 |
| Shares Outstanding (Diluted) | 14 | 4 | 4 |
| Shares Change (YoY) | 249.74% | 4.62% | - |
| EPS (Basic) | -2.12 | -6.11 | -4.86 |
| EPS (Diluted) | -2.12 | -6.11 | -4.86 |
| Free Cash Flow | -29.62 | -25.65 | -17.62 |
| Free Cash Flow Per Share | -2.08 | -6.31 | -4.53 |
| Gross Margin | 75.31% | 73.80% | 71.88% |
| Operating Margin | -60.53% | -88.80% | -134.93% |
| Profit Margin | -59.82% | -91.47% | -137.16% |
| Free Cash Flow Margin | -58.64% | -94.41% | -127.85% |
| EBITDA | -30.29 | -23.98 | -18.46 |
| EBITDA Margin | -59.97% | -88.26% | -133.94% |
| D&A For EBITDA | 0.28 | 0.15 | 0.14 |
| EBIT | -30.57 | -24.12 | -18.59 |
| EBIT Margin | -60.53% | -88.80% | -134.93% |
Source: S&P Capital IQ. Standard template.
Financial Sources.